Skip to content
User

Viking Global Investors MANE trades

Ole Andreas Halvorsen

Ole Andreas Halvorsen Veradermics, Incorporated stake

total: 682

Trades details

Total transactions:
3
New positions:
1
Sold out:
1
Reduced:
1
Held since:
2026 Q1
Held for:
2 quarters
Latest activity:
2026 Q3
According to 2026 Q3 report, Ole Andreas Halvorsen doesn't hold any Veradermics, Incorporated (MANE) shares. To date, the estimated cost basis is nearly $63.15 for "buy" trades and estimated average "sell" price is $122.94. Viking Global Investors first purchased MANE in 2026 Q1, initially acquiring about 1.69M shares. Since the initial investment in Veradermics, Incorporated (MANE), Viking Global Investors has made 2 more transactions.

When did Ole Andreas Halvorsen sell Veradermics, Incorporated (MANE)?

Ole Andreas Halvorsen sold off the entire Veradermics, Incorporated (MANE) position in 2026 Q3.

When did Ole Andreas Halvorsen buy Veradermics, Incorporated (MANE)?

Ole Andreas Halvorsen first invested in Veradermics, Incorporated (MANE) in 2026 Q1 at the reported quarter-end price of $63.15 per share.

What's the cost basis of Viking Global Investors's MANE stake?

The estimated cost basis for Veradermics, Incorporated (MANE) stake is around $63.15 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$63.15
Weighted AVG sell price:
$122.94

Ole Andreas Halvorsen's historical trades in Veradermics, Incorporated

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q3
0.00%
0
$122.94
-100% (-1,561,494)
-0.55%
2026 Q2
0.55%
1,561,494
$122.94
$191,970,072
-7.63% (-129,061)
-0.04%
2026 Q1
0.30%
1,690,555
$63.15
$106,758,548
new
+0.3%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.